توقعات سوق علم الفيروسات في أوروبا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب النوع (الاختبار التشخيصي، وتقنيات مكافحة العدوى الفيروسية، والعلاجات المضادة للفيروسات، والإنترفيرون)، والتطبيق (التهابات الجلد والأنسجة الرخوة، والتهابات الجهاز التنفسي، والتهابات الجهاز الهضمي، المنقولة جنسيًا الأمراض وعدوى المسالك البولية وغيرها)، والمستخدم النهائي (المستشفيات، ومختبرات التشخيص، وشركات الأدوية والتكنولوجيا الحيوية، والمعاهد البحثية والأكاديمية)

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Virology Market – By Type

1.3.2        Europe Virology Market – By Application

1.3.3        Europe Virology Market – By End User

1.3.4        Europe Virology Market– By Country

2.           Europe Virology Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Virology Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Virology Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Viral Infectious Diseases

5.1.2        Increasing Product Launches

5.2         Market Restraints

5.2.1        Availability of Alternative Products and High Cost of Production of Products

5.3         Market Opportunities

5.3.1        Growth Potential in Several Economies

5.4         Future Trends

5.4.1        Continuous Demand for Cost-Effective Products

5.5         Impact Analysis

6.           Virology Market– Europe Analysis

6.1         Europe Virology Market Revenue Forecast and Analysis

7.           Europe Virology Market Analysis – By Type

7.1         Overview

7.2         Europe Virology Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Test

7.3.1        Overview

7.3.2        Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1          Overview

7.3.2.1.2          DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1          Overview

7.3.2.2.2          RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Others

7.3.2.3.1          Overview

7.3.2.3.2          Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Viral Infection Controlling Techniques

7.4.1        Overview

7.4.2        Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1          Active Prophylaxis

7.4.2.1.1          Overview

7.4.2.1.2          Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2          Passive Prophylaxis

7.4.2.2.1          Overview

7.4.2.2.2          Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Antiviral Therapeutics

7.5.1        Overview

7.5.2        Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1          Virucidal Agents

7.5.2.1.1          Overview

7.5.2.1.2          Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2          Antiviral Agents

7.5.2.2.1          Overview

7.5.2.2.2          Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3          Immunomodulators

7.5.2.3.1          Overview

7.5.2.3.2          Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Interferons

7.6.1        Overview

7.6.2        Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Virology Market Analysis – By Application

8.1         Overview

8.2         Europe Virology Market, by Application 2021 & 2028 (%)

8.3         Skin and Soft Tissue Infections

8.3.1        Overview

8.3.2        Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Respiratory Tract Infections

8.4.1        Overview

8.4.2        Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5         GI Tract Infections

8.5.1        Overview

8.5.2        GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Sexually Transmitted Diseases

8.6.1        Overview

8.6.2        Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Urinary Tract Infections

8.7.1        Overview

8.7.2        Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Virology Market Analysis – By End User

9.1         Overview

9.2         Europe Virology Market Revenue Share, by End User (2021 and 2028)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Diagnostic Laboratories

9.4.1        Overview

9.4.2        Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pharmaceutical and Biotechnological Companies

9.5.1        Overview

9.5.2        Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Research and Academic Institutes

9.6.1        Overview

9.6.2        Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Virology Market – Country Analysis

10.1.1     Europe Virology Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1       UK Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.1.1       UK Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.1.2       UK Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.1.2.1    UK: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.1.2.2    UK: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.1.2.3    UK: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.1.3       UK Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.1.4       UK Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.2       Germany Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.2.1       Germany Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.2.2       Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.2.2.1    Germany: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.2.2.2    Germany: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.2.2.3    Germany: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.2.3       Germany Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.2.4       Germany Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.3       France Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.3.1       France Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.3.2       France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.3.2.1    France: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.3.2.2    France: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.3.2.3    France: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.3.3       France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.3.4       France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.4       Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.4.1       Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.4.2       Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.4.2.1    Italy: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.4.2.2    Italy: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.4.2.3    Italy: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.4.3       Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.4.4       Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.5       Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.5.1       Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.5.2       Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.5.2.1    Spain: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.5.2.2    Spain: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.5.2.3    Spain: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.5.3       Spain Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.5.4       Spain Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

10.1.1.6       Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.6.1       Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

10.1.1.6.2       Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

10.1.1.6.2.1    Rest of Europe: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.1.6.2.2    Rest of Europe: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.1.6.2.3    Rest of Europe: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.1.6.3       Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

10.1.1.6.4       Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

11.        Impact of COVID-19 Pandemic on Europe Virology Market

11.1      Overview

12.        Europe Virology Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Abbott

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Johnson and Johnson Services, Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      F. HOFFMANN-LA ROCHE LTD.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      THERMO FISHER SCIENTIFIC INC.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      QIAGEN

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Illumina, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      GlaxoSmithKline Plc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      AbbVie Inc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Gilead Sciences, Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             Europe Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             UK Virology Market Revenue and Forecasts to 2028, By Type US$ million)

Table 3.             UK Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4.             UK Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5.             UK Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6.             UK Virology Market Revenue and Forecasts to 2028, by Application US$ million)

Table 7.             UK Virology Market Revenue and Forecasts to 2028, by End User US$ million)

Table 8.             Germany Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 9.             Germany Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10.          Germany Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11.          Germany Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12.          Germany Virology Market Revenue and Forecasts to 2028, by Application US$ million)

Table 13.          Germany Virology Market Revenue and Forecasts to 2028, by End User US$ million)

Table 14.          France Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 15.          France Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16.          France Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17.          France Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18.          France Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 19.          France Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 20.          Italy Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 21.          Italy Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22.          Italy Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23.          Italy Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24.          Italy Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 25.          Italy Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 26.          Spain Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 27.          Spain Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 28.          North America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 29.          Spain Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 30.          Spain Virology Market, by Application – Revenue and Forecast to 2028 by Application (USD Million)

Table 31.          Spain Virology Market, by End User – Revenue and Forecast to 2028 by End User (USD Million)

Table 32.          Rest of Europe Virology Market Revenue and Forecasts to 2028, By Type (US$ million)

Table 33.          Rest of Europe Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 34.          Rest of Europe Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 35.          Rest of Europe Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Europe Virology Market Revenue and Forecasts to 2028, by Application (US$ million)

Table 37.          Rest of Europe Virology Market Revenue and Forecasts to 2028, by End User (US$ million)

Table 38.          Organic Developments Done by Companies

Table 39.          Inorganic Developments Done by Companies

Table 40.          Glossary of Terms, Europe Virology Market

Figure 1.           Europe Virology Market Segmentation

Figure 2.           Europe Virology Segmentation, By Country

Figure 3.           Europe Virology Market Overview

Figure 4.           Antiviral Therapeutics Held the Largest Share of the Type Segment in Europe Virology Market

Figure 5.           Respiratory Tract Infections Held the Largest Share of the Application Segment in Europe Virology Market

Figure 6.           UK to Show Significant Growth During Forecast Period

Figure 7.           Europe and PEST Analysis

Figure 8.           Europe Virology Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        Europe Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11.        Europe Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Europe DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Europe Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Europe Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Europe Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Europe Antiviral Therapeutics : Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Europe Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe Virology Market, by Application 2021 & 2028 (%)

Figure 24.        Europe Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Europe Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Europe Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Europe Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Europe Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31.        Europe Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Europe Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Europe Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Europe Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Europe: Virology Market Revenue Overview, by Country, 2021 (US$ MN)

Figure 36.        Europe Virology Market Revenue and Forecasts to 2028, By Country (%)

Figure 37.        UK Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 38.        Germany Virology Products Market Revenue and Forecasts to 2028 (US$ million)

Figure 39.        France Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 40.        Italy Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 41.        Spain Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 42.        Rest of Europe Virology Market Revenue and Forecasts to 2028 (US$ million)

Figure 43.        Impact of COVID-19 Pandemic on Virology Market in European Countries

1. Abbott
2. AbbVie Inc.
3. F. Hoffmann-La Roche Ltd.
4. Gilead Sciences, Inc.
5. GlaxoSmithKline Plc
6. Illumina, Inc.
7. Johnson and Johnson Services, Inc.
8. QIAGEN
9. Siemens AG
10. Thermo Fisher Scientific Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Virology market.
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe Virology market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution